Dipna Pharmachem Ltd
Open - 25 August
Close - 30 August
Price - 15.2 ₹ 38/ equity share
The P/E ratio is of 26 which is better than the industry, The Earnings per share (EPS) is around 335 , which is again better than the industry. Dipna Pharmachem Ltd has shown 4600% year on year growth in its Profit after tax and 132% year on year growth in Revenue making this IPO attractive. Apply using NetBanking or ASBA Process. Incorporated in 2011, Dipna Pharmachem Limited is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), The Company also started selling chemicals on a commission basis in the Financial year 2022. The company conducts business in Ahmedabad and the surrounding areas. The company's product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti - Bacteria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc. The company is supplying raw materials to pharmaceutical industries and the pharmaceutical industry falls under the essential business list declared by the Government.
DIPNAPHARMA.IPOINFO.IN
No comments:
Post a Comment